Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Sickle Cell Disease (Adults)

Management of Vaso-Occlusive Crisis and Acute Chest Syndrome—Oxygen Supplementation

Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease.

Ip H, Kesse-Adu R, Howard J, Hart N.

Source‎: Br J Haematol 2013;161(3):455-6.

Indexed‎: PubMed 23419066

DOI‎: 10.1111/bjh.12254

Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease.

Stirnemann J, Letellier E, Aras N, Borne M, Brinquin L, Fain O.

Source‎: Diving Hyperb Med 2012;42(2):82-4.

Indexed‎: PubMed 22828815

Guidelines for the management of the acute painful crisis in sickle cell disease.

Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J; British Committee for Standards in Haematology General Haematology Task Force by the Sickle Cell Working Party.

Source‎: Br J Haematol 2003;120(5):744-52.

Indexed‎: PubMed 12614204

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.